骨膜蛋白在肿瘤微环境中的作用研究进展

doi:10.19586/j.2095-2341.2023.0153

生物技术进展 ›› 2024, Vol. 14 ›› Issue (2): 205-210.DOI: 10.19586/j.2095-2341.2023.0153

• 进展评述 • 上一篇

骨膜蛋白在肿瘤微环境中的作用研究进展

布尔兰·叶尔肯别克¹(), 郭文佳¹, 董晓刚²()

^1.新疆医科大学附属肿瘤医院肿瘤防治研究所，乌鲁木齐 830011
^2.新疆医科大学附属肿瘤医院肝胆胰外科，乌鲁木齐 830011

收稿日期:2023-11-30 接受日期:2024-02-05 出版日期:2024-03-25 发布日期:2024-04-17
通讯作者: 董晓刚
作者简介:布尔兰·叶尔肯别克E-mail: buerlan@stu.xjmu.edu.cn;
基金资助:
新疆维吾尔自治区重点实验室开放课题(2022D04021);新疆维吾尔自治区“天池英才”计划项目(2022TCYCDXG)

Advances on the Function of POSTN in Tumor Microenvironment

Yeerkenbieke BUERLAN¹(), Wenjia GUO¹, Xiaogang DONG²()

^1.Department of Cancer Research Institute，Affiliated Cancer Hospital of Xinjiang Medical University，Urumqi 830011，China
^2.Department of Hepatobiliary and Pancreatic Surgery，Affiliated Cancer Hospital of Xinjiang Medical University，Urumqi 830011，China

Received:2023-11-30 Accepted:2024-02-05 Online:2024-03-25 Published:2024-04-17
Contact: Xiaogang DONG

摘要/Abstract

摘要：

肿瘤微环境对肿瘤的发展起重要作用，而肿瘤微环境中的细胞外基质蛋白在肿瘤细胞增殖、转移、免疫逃逸及对化疗的耐药等生物特性调节中发挥着关键作用。充分理解肿瘤微环境中各分子相互作用机制并及时给予有效的干预措施，有助于探索新的治疗靶点并抑制肿瘤进展。近期研究表明，骨膜蛋白（periostin, POSTN）作为细胞外基质蛋白中的一种重要成分，参与了多种肿瘤的生物学过程，并与肿瘤微环境中多个环节相关。从肿瘤微环境出发，总结了骨膜蛋白在肿瘤发生发展中的最新研究进展，以探讨骨膜蛋白能否成为潜在的肿瘤治疗靶点。

关键词: 骨膜蛋白, 肿瘤微环境, 生物标志物

Abstract:

Tumor microenvironment has been recognized as an important part of tumor development. Extracellular matrix proteins present in tumor microenvironment play key roles in biological regulation of tumor cells such as unlimited proliferation， metastasis， immune escape and drug resistance to chemotherapy. Fully understanding the molecular interaction mechanism in the tumor microenvironment and giving effective intervention measures in time would help to explore new therapeutic targets and inhibit tumor progression. According to recent research， periostin （POSTN）， one of extracellular matrix proteins， interacts with numerous components of the tumor microenvironment and is also involved in the biological processes of many malignancies. In order to determine the possibility of POSTN as a therapeutic target， this review presented the recent findings about the involvement of POSTN in the incidence and development of malignancies from the viewpoint of the tumor microenvironment.

Key words: periostin, tumor microenvironment, biomarkers

中图分类号:

Q816

布尔兰·叶尔肯别克, 郭文佳, 董晓刚. 骨膜蛋白在肿瘤微环境中的作用研究进展[J]. 生物技术进展, 2024, 14(2): 205-210.

Yeerkenbieke BUERLAN, Wenjia GUO, Xiaogang DONG. Advances on the Function of POSTN in Tumor Microenvironment[J]. Current Biotechnology, 2024, 14(2): 205-210.

图/表 2

参考文献 41

1	WANG Z, AN J, ZHU D, et al.. Periostin: an emerging activator of multiple signaling pathways[J]. J. Cell Commun. Signal., 2022, 16(4): 515-530.
2	张鹏晓,胡念.黑色素瘤免疫治疗作用机制研究进展[J].生物技术进展,2023,13(6):900-906.
	ZHANG P X, HU N. The research progress on action mechanism of melanoma immunotherapy[J]. Curr. Biotechnol., 2023, 13(6): 900-906.
3	PICKERING M E, ORIS C, CHAPURLAT R. Periostin in osteoporosis and cardiovascular disease[J/OL]. J. Endocr. Soc., 2023, 7(7): bvad081[2024-01-20]. .
4	YUE H, LI W, CHEN R, et al.. Stromal POSTN induced by TGF-β1 facilitates the migration and invasion of ovarian cancer[J]. Gynecol. Oncol., 2021, 160(2): 530-538.
5	KUDO A. The structure of the periostin gene, its transcriptional control and alternative splicing, and protein expression[J]. Adv. Exp. Med. Biol., 2019, 1132: 7-20.
6	JANJIĆ K, AGIS H, MORITZ A, et al.. Effects of collagen membranes and bone substitute differ in periodontal ligament cell microtissues and monolayers[J]. J. Periodontol., 2022, 93(5): 697-708.
7	曾峰,黄建芬,余新林,等.骨膜蛋白的研究新进展[J].中国医学创新,2021,18(7):171-176.
	ZENG F, HUANG J F, YU X L, et al.. New progress in the study of perostin[J]. Med. Innov. China, 2021, 18(7): 171-176.
8	YANG L, GUO T, CHEN Y, et al.. The multiple roles of periostin in non-neoplastic disease[J/OL]. Cells, 2022, 12(1): 50[2024-01-20]. .
9	方学升,包明威.骨膜蛋白在心血管疾病中的研究进展[J].生物技术进展,2023,13(5):725-729.
	FANG X S, BAO M W. Research advances of POSTN in cardiovascular diseases[J]. Curr. Biotechnol., 2023, 13(5): 725-729.
10	SONNENBERG-RIETHMACHER E, MIEHE M, RIETHMACHER D. Periostin in allergy and inflammation[J/OL]. Front. Immunol., 2021, 12: 722170[2024-01-20]. .
11	XUE K, CHEN S, CHAI J, et al.. Upregulation of periostin through CREB participates in myocardial infarction-induced myocardial fibrosis[J]. J. Cardiovasc. Pharmacol., 2022, 79(5): 687-697.
12	DU K, WANG M, ZHANG N, et al.. Involvement of the extracellular matrix proteins periostin and tenascin C in nasal polyp remodeling by regulating the expression of MMPs[J/OL]. Clin. Transl. Allergy, 2021, 11(7): e12059[2024-01-20]. .
13	DUAN X, CAI L, PHAM C T N, et al.. Amelioration of posttraumatic osteoarthritis in mice using intraarticular silencing of periostin via nanoparticle-based small interfering RNA[J]. Arthritis. Rheumatol., 2021, 73(12): 2249-2260.
14	LUO H, XIA X, HUANG L B, et al.. Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment[J/OL]. Nat. Commun., 2022, 13: 6619[2024-01-20]. .
15	LIN S C, LIAO Y C, CHEN P M, et al.. Periostin promotes ovarian cancer metastasis by enhancing M2 macrophages and cancer-associated fibroblasts via integrin-mediated NF-κB and TGF-β2 signaling[J/OL]. J. Biomed. Sci., 2022, 29(1): 109[2024-01-20]. .
16	LI X, SUN Z, PENG G, et al.. Single-cell RNA sequencing reveals a pro-invasive cancer-associated fibroblast subgroup associated with poor clinical outcomes in patients with gastric cancer[J]. Theranostics, 2022, 12(2): 620-638.
17	KAMALI ZONOUZI S, PEZESHKI P S, RAZI S, et al.. Cancer-associated fibroblasts in colorectal cancer[J]. Clin. Transl. Oncol., 2022, 24(5): 757-769.
18	SURESH A, BISWAS A, PERUMAL S, et al.. Periostin and integrin signaling in stem cell regulation[J]. Adv. Exp. Med. Biol., 2019, 1132: 163-176.
19	WASIK A, RATAJCZAK-WIELGOMAS K, BADZINSKI A, et al.. The role of periostin in angiogenesis and lymphangiogenesis in tumors[J/OL]. Cancers, 2022, 14(17): 4225[2024-01-20]. .
20	MA Z, ZHAO X, DENG M, et al.. Bone marrow mesenchymal stromal cell-derived periostin promotes B-ALL progression by modulating CCL2 in leukemia cells[J]. Cell Rep., 2019, 26(6): 1533-1543.
21	ZHUANG Y, ZHAO Z, CHENG M, et al.. HIF-1α regulates osteogenesis of periosteum-derived stem cells under hypoxia conditions via modulating POSTN expression[J/OL]. Cell Dev. Biol., 2022, 10: 836285[2024-01-20]. .
22	DORAFSHAN S, RAZMI M, SAFAEI S, et al.. Periostin: biology and function in cancer[J/OL]. Cancer Cell Int., 2022, 22(1): 315[2024-01-20]. .
23	WANG Z, AN J, ZHU D, et al.. Periostin: an emerging activator of multiple signaling pathways[J]. J. Cell Commun. Signal, 2022, 16(4): 515-530.
24	OUANOUKI A, LAMY S, ANNABI B. Periostin a signal transduction intermediate in TGF-β-induced EMT in U-87MG human glioblastoma cells, and its inhibition by anthocyanidins[J]. Oncotarget, 2018, 9(31): 22023-22037.
25	TEWARI D, PATNI P, BISHAYEE A, et al.. Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: a novel therapeutic strategy[J]. Semin. Cancer Biol., 2022, 80: 1-17.
26	PENG Y, WANG Y, ZHOU C, et al.. PI3K/akt/mTOR pathway and its role in cancer therapeutics: are we making headway?[J/OL]. Front. Oncol., 2022, 12: 819128[2024-01-20]. .
27	WANG J, HU K, CAI X, et al.. Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis[J]. Acta Pharm. Sin. B, 2022, 12(1): 18-32.
28	CHEN J, WANG L, YUAN M. Update on the roles of rice MAPK cascades[J/OL]. Int. J. Mol. Sci., 2021, 22(4): 1679[2024-01-20]. .
29	LIU Y, LUAN Y, GUO Z, et al.. Periostin attenuates oxygen and glucose deprivation-induced death of mouse neural stem cells via inhibition of p38 MAPK activation[J/OL]. Neurosci. Lett., 2022, 774: 136526[2024-01-20]. .
30	MO Y, ZHANG K, FENG Y, et al.. Epithelial SERPINB10, a novel marker of airway eosinophilia in asthma, contributes to allergic airway inflammation[J]. Am. J. Physiol. Lung Cell Mol. Physiol., 2019, 316(1): 245-254.
31	AN J N, YANG S H, KIM Y C, et al.. Periostin induces kidney fibrosis after acute kidney injury via the p38 MAPK pathway[J]. Am. J. Physiol. Ren. Physiol., 2019, 316(3): 426-437.
32	JIA Y Y, YU Y, LI H J. POSTN promotes proliferation and epithelial-mesenchymal transition in renal cell carcinoma through ILK/AKT/mTOR pathway[J]. J. Cancer, 2021, 12(14): 4183-4195.
33	CHEN G, WANG Y, ZHAO X, et al.. A positive feedback loop between Periostin and TGFβ1 induces and maintains the stemness of hepatocellular carcinoma cells via AP-2α activation[J/OL]. J. Exp. Clin. Cancer Res., 2021, 40(1): 218[2024-01-20]. .
34	XU C, WANG Z, ZHANG L, et al.. Periostin promotes the proliferation and metastasis of osteosarcoma by increasing cell survival and activates the PI3K/Akt pathway[J/OL]. Cancer Cell Int., 2022, 22(1): 34[2024-01-20]. .
35	GILLOT L, LEBEAU A, BAUDIN L, et al.. Periostin in lymph node pre-metastatic niches governs lymphatic endothelial cell functions and metastatic colonization[J/OL]. Cell. Mol. Life Sci., 2022, 79(6): 295[2024-01-20]. .
36	SONONGBUA J, SIRITUNGYONG S, THONGCHOT S, et al.. Periostin induces epithelial-to-mesenchymal transition via the integrin α5β1/TWIST-2 axis in cholangiocarcinoma[J]. Oncol. Rep., 2020, 43(4): 1147-1158.
37	SIRICA A E. Matricellular proteins in intrahepatic cholangiocarcinoma[J]. Adv. Cancer Res., 2022, 156: 249-281.
38	SUN D, GAI Z, WU J, et al.. Prognostic impact of the angiogenic gene POSTN and its related genes on lung adenocarcinoma[J/OL]. Front. Oncol. 2022,27(12):699824[2022-06-12]. .
39	KUDO Y, IIZUKA S, YOSHIDA M, et al.. Periostin directly and indirectly promotes tumor lymphangiogenesis of head and neck cancer[J/OL]. PLoS ONE, 2012, 7(8): e44488[2024-01-20]. .
40	LIU Y, GAO F, SONG W. Periostin contributes to arsenic trioxide resistance in hepatocellular carcinoma cells under hypoxia[J]. Biomed. Pharmacother., 2017, 88: 342-348.
41	STERZYŃSKA K, KAŹMIERCZAK D, KLEJEWSKI A, et al.. Expression of osteoblast-specific factor 2 (OSF-2, periostin) is associated with drug resistance in ovarian cancer cell lines[J/OL]. Int. J. Mol. Sci., 2019, 20(16): 3927[2024-01-20]. .

[1]	张鹏晓, 胡念. 黑色素瘤免疫治疗作用机制研究进展[J]. 生物技术进展, 2023, 13(6): 900-906.
[2]	曹克浩, 朱军利, 何华山, 徐慰倬. 专利法第四次修改对生物技术专利申请和产业发展的影响[J]. 生物技术进展, 2023, 13(5): 663-670.
[3]	杜琳琳, 谢飞, 马雪梅. SALL4的促癌功能及治疗意义[J]. 生物技术进展, 2023, 13(5): 704-711.
[4]	安外尔·约麦尔阿卜拉, 孙莉莉, 布尔兰·叶尔肯别克, 郭文佳. Piezo1在癌症中的作用研究进展[J]. 生物技术进展, 2023, 13(5): 712-717.
[5]	方学升, 包明威. 骨膜蛋白在心血管疾病中的研究进展[J]. 生物技术进展, 2023, 13(5): 725-729.
[6]	李永超, 杨昭. 双特异抗体药物研发现状及发展对策[J]. 生物技术进展, 2023, 13(3): 353-358.
[7]	于敏, 王敏, 魏延焕, 刘毅毅. SARS-CoV-2病毒感染潜在关键分子生物标志物及免疫浸润特征分析[J]. 生物技术进展, 2022, 12(5): 760-768.
[8]	雍嘉欣, 韦权峰, 刘尚辉. 基于TCGA和GEO数据库的胃癌lncRNA筛选与ceRNA网络构建[J]. 生物技术进展, 2022, 12(1): 149-157.
[9]	廖桃桃,汤俊杰,史潇翔,张伟杰,茆广华,吴向阳. 十溴联苯醚（BDE-209）短期暴露对成年期小鼠的免疫毒性研究[J]. 生物技术进展, 2021, 11(2): 204-213.
[10]	王瑞,李亮. 环状RNA及其在生态毒理学研究中的应用进展[J]. 生物技术进展, 2021, 11(1): 16-25.
[11]	刘梦昱,谢飞,张鑫,赵鹏翔,. 胶质母细胞瘤相关分子标志物研究进展[J]. 生物技术进展, 2019, 9(2): 129-138.

骨膜蛋白在肿瘤微环境中的作用研究进展

Advances on the Function of POSTN in Tumor Microenvironment

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

图/表 2

参考文献 41

相关文章 11

编辑推荐

Metrics

本文评价